Novo Nordisk has signed an exclusive global licensing deal worth up to $2 billion for UBT251, a weight-loss drug developed by ...

Wegovy is also available through NovoCare Pharmacy, which directly ship all dose strengths at a cost of $499 per month for ...

New research suggests that drugs like Ozempic may provide more health benefits than previously thought. These medications, ...

Stopping Ozempic injections for weight loss can cause weight gain and a possible increase in blood sugar and blood pressure. To restart Ozempic treatment, a doctor will slowly increase your dose ...

The Food and Drug Administration (FDA) approved Ozempic to reduce the risk of worsening kidney disease and death from cardiovascular disease in adults with type 2 diabetes and chronic kidney disease.

Novo Nordisk agreed to pay up to $2 billion for the rights to a developmental weight-loss and obesity drug from Chinese pharmaceutical company the United Bio-Technology (Hengqin) Co., as it looks to ...

Medadvisor doesn’t make vaccines, but it helps vaccine makers to promote the importance of immunisation (and boost sales of ...

Nothing drives down a drug’s price like competition. According the U.S. Food and Drug Administration (FDA), a drug’s ...

Eli Lilly's much-anticipated drug for diabetes and obesity, that competes with Ozempic globally, is now in India. Here's what ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...